Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.185ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.185ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.185NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.258.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.258.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.329ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.329ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.329ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.329NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.229ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.229ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.229ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.229NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.342ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.342ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.342ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.342NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.90ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.90ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.90ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.90NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.169ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.169ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.169ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.169NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.53ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.53NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.528ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.528ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.528ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.528NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.175ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.175ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.175ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.175NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.6.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.6.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.483ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.483ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.483ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used